May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
Proteomic Analysis of Human Meibomian Gland Secretions
Author Affiliations & Notes
  • J.E. Evans
    University of Massachusetts Medical School, Worcester, MA, United States
  • K.M. Green
    University of Massachusetts Medical School, Worcester, MA, United States
  • R.M. Sullivan
    Schepens Eye Research Institute, Boston, MA, United States
  • D.A. Schaumberg
    Schepens Eye Research Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
  • M.R. Dana
    Schepens Eye Research Institute, Mass Eye and Ear Infirmary and Harvard Medical School, Boston, MA, United States
  • D.A. Sullivan
    Schepens Eye Research Institue and Harvard Medical School, Boston, MA, United States
  • Footnotes
    Commercial Relationships  J.E. Evans, None; K.M. Green, None; R.M. Sullivan, None; D.A. Schaumberg, None; M.R. Dana, None; D.A. Sullivan, Allergan F, C.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2478. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.E. Evans, K.M. Green, R.M. Sullivan, D.A. Schaumberg, M.R. Dana, D.A. Sullivan; Proteomic Analysis of Human Meibomian Gland Secretions . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2478.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Researchers have recently identified over 490 proteins in the human tear film. We hypothesize that many of these proteins originate from the meibomian gland, and influence both tear film stability and ocular surface integrity. Our rationale is that the meibomian gland is a large sebaceous gland, and sebaceous glands are known to secrete a variety of proteins (e.g. IgA, pro-inflammatory cytokines) and lipids in non-ocular sites. The purpose of this study was to develop the proteomic methodology to permit the testing of our hypothesis. Methods: Meibomian gland secretions were collected from the left and right lower eyelids of male and female volunteers (n = 7) and placed in a chloroform-methanol mixture. Samples were processed by partitioning in a chloroform-methanol-water biphasic system. The upper non-lipid phase materials were reduced with dithiothreitol, alkylated using iodoacetamide, and trypsin digested in 8 M urea to obtain peptides for microcapillary (µ) HPLC/mass spectrometry (MS)/MS protein identification. This peptide mixture was separated by µ-capillary reverse phase chromatography and the effluent analyzed by online MS and MS/MS using an ion trap mass spectrometer. The MS/MS spectra from the tryptic peptides detected were used to identify the proteins present in the samples using SEQUEST software for comparison to protein databases. Results: Our methodologic approach to date has permitted the identification of over 15 proteins in meibomian gland secretions. Proteins include Tro alpha 1 H (an IgA heavy chain variant), farnesoid-X receptor (a regulator of cholesterol homeostasis), megakaryocyte associated tyrosine kinase and keratin 10. However, we have yet to completely optimize our analytical procedures (e.g. for removing salts, reducing possible interference by glycosylated peptides), or to apply more sensitive and specific µLC/µLC/MS/MS techniques (MudPIT). Conclusions: . Our findings indicate that the meibomian gland may secrete a number of proteins into the tear film. (Supported by research grants from Allergan, NIHEY05612 and the SERI/MEEI Joint Clinical Research Center)

Keywords: cornea: tears/tear film/dry eye 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.